Release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine.
Steven Pincus
Advertisement
Steven Pincus is the head of analytical and quality operations at Novavax Inc.
Articles by Steven Pincus
Advertisement
Latest Updated Articles
Release and Stability Testing Programs for a Novel Virus-Like Particle VaccinePublished: October 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
